Analytical Framework for Examining the Value of Antibacterial Products. 5.1.9 Product Launch Success Probability

04/15/2014

According to Griffin (1997), only about 60 percent of new product launches end up being commercially successful.  As we did for antibacterial drugs and vaccines previously, we use this as our basis for new rapid POC diagnostics.  For sensitivity analysis, we use a triangular distribution for the product success probability with a lower bound of 40 percent and an upper bound of 80 percent.

View full report

Preview
Download

"rpt_antibacterials.pdf" (pdf, 1.43Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®